BioHealth News
I-Mab Focuses on Advancing Givastomig as Lead Cancer Therapy in Clinical Development
ROCKVILLE, MD, Jan. 6, 2025 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the…
Read MoreBuilding Montgomery County’s Future: Economic Growth and Innovation with MCEDC’s Bill Tompkins on BioTalk
[vc_row type="in_container" full_screen_row_position="middle" column_margin="default" column_direction="default" column_direction_tablet="default" column_direction_phone="default" scene_position="center" text_color="dark" text_align="left" row_border_radius="none" row_border_radius_applies="bg" overlay_strength="0.3" gradient_direction="left_to_right" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding" column_padding_tablet="inherit" column_padding_phone="inherit" column_padding_position="all" column_element_spacing="default" background_color_opacity="1" background_hover_color_opacity="1" column_shadow="none"…
Read MoreMEDTECHDRIVE Q&A: Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.
Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children…
Read MoreGermantown’s Precigen Seeks FDA Approval with Priority Review for New Treatment for Recurrent Respiratory Papillomatosis in Adults
Precigen has submitted a Biologics License Application (BLA) to the FDA, seeking priority review for PRGN-2012, which could become the first FDA-approved treatment for…
Read MoreAdvancing Biomedical Innovation: ARPA-H’s Transformative 2024 Highlights
BHI is proud to support ARPA-H through its Partnership Intermediary Agreement (PIA), providing EIR commercialization services to advance groundbreaking technologies. Notably, BaySpec, one of…
Read MoreGovernor Moore Signs Executive Order to Bolster Maryland’s Economic Competitiveness
DEC 20, ANNAPOLIS, MD — Governor Wes Moore today signed an executive order to strengthen Maryland’s business climate and catalyze more economic growth in the state. The…
Read MoreArnold Consultancy & Technology, LLC Awarded $357,000 Phase I Grant to develop a Health Economic Model Marketplace
National Cancer Institute (NCI) has awarded a $357,000 SBIR grant to Arnold Consultancy & Technology, LLC to develop an open source model marketplace. MIAMI…
Read MoreSpotlighting Growth and Collaboration in Life Sciences—Insights from Rachel Rath, Head of JLABS @ Washington, DC
BHI is excited to highlight Rachel Rath’s recent LinkedIn Post, where she reflects on her first 90 days as Head of JLABS @ Washington,…
Read MoreUncommon Cures and TASK Partner to Advance Clinical Trials for Orphan Drugs Across Europe and South Africa
Chevy Chase, MD, 2 December 2024 – Uncommon Cures®, a pioneering organization dedicated to accelerating the development of orphan drugs, has announced a strategic…
Read MoreChildren’s National SPARK Symposium and Ribbon-Cutting Launch
Children’s National Innovation Ventures is hosting the Symposium on Pediatric Medical Countermeasures (MCMs) and the SPARK for Innovations in Pediatrics Launch and Prize Competition—a…
Read MorePQE Group Receives Certifications from ISO/IEC 27001 and A Women’s Business Enterprise
Italy, December 23, 2024. PQE Group is proud to announce its most recently-received official recognitions: ISO/IEC 27001 and A Women’s Business Enterprise (WBE) Certifications,…
Read MoreWashington Mayor Bowser Launches $26 Million Fund to Drive New Venture Capital Investments to DC-Based Start-Ups
Monday, December 16, 2024 (Washington, DC) – Today, Mayor Muriel Bowser launched the DC Venture Capital Program, a new $26 million fund designed to…
Read MoreUnited Therapeutics Announces Successful World’s First UKidney Transplant
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first transplant of a…
Read MorePMF: How to pitch to investors. The startup pitch framework + data room template + what only 1% entrepreneurs do + favorite deck slides
Guillermo Flor - How to pitch to investorsThe basics:1. Venture Capitalists have an investment thesis they have to follow. If your startup doesn’t fit…
Read MoreEmergent BioSolutions Secures $50M BARDA Contract to Supply CYFENDUS® Anthrax Vaccine
GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness…
Read More